Taro Pharmaceutical Industries Ltd. Provides Preliminary 2008 Full Year Results; Net Income in 2008 Increases 143% to $51 Million From $21 Million in 2007

HAWTHORNE, N.Y., Feb. 2, 2009 (GLOBE NEWSWIRE) -- Taro Pharmaceutical Industries Ltd. (“Taro,” the “Company,”) (Pink Sheets:TAROF) today provided preliminary, unaudited and unreviewed information on its financial performance for the year ended December 31, 2008.